Cleared Traditional

K973371 - CERTODYN RAECG UNIVERSAL ADAPTER

K973371 is the FDA 510(k) clearance for CERTODYN RAECG UNIVERSAL ADAPTER by B.Braun Medical, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 77-day FDA review.

K973371 · B.Braun Medical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1997
Decision
77d
Days
Class 2
Risk

K973371 is an FDA 510(k) clearance for the CERTODYN RAECG UNIVERSAL ADAPTER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by B.Braun Medical, Inc. (Bethlehem, US). The FDA issued a Cleared decision on November 24, 1997 after a review of 77 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all B.Braun Medical, Inc. devices

Submission Details

510(k) Number K973371 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 1997
Decision Date November 24, 1997
Days to Decision 77 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 125d · This submission: 77d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 577
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K973371.
SCHNEIDER GUIDER SOFTIP GUIDING CATHETERS
K980453 · Boston Scientific Scimed, Inc. · Aug 1998
SCHNEIDER GUIDER SOFTIP GUIDING CATHETERS
K981413 · Boston Scientific Scimed, Inc. · May 1998
SCIMED 7 FRENCH WISEGUIDE GUIDE CATHETER
K974684 · Scimed Life Systems, Inc. · Feb 1998
VISTA BRITE TIP GUIDING CATHETERS
K972978 · Cordis Corp. · Oct 1997
ACS VIKING GUIDING CATHETER
K972484 · Guidant Corp. · Sep 1997
ENVOY GUIDING CATHETER
K965247 · Cordis Neurovascular, Inc. · Jul 1997